COVID-19 Delayed Cancer Treatment, Diagnoses
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read More
Search Results for: prostate cancer
Long-Term Study Validates Genomic Assay for Prostate Cancer
Exact Sciences has announced results underscoring the importance of adverse pathology as a reliable and critical endpoint for prostate cancer patients.
Read More
FDA Grants Breakthrough Designation for Breast Cancer Detection Test
The US Food and Drug Administration (FDA) has granted ‘Breakthrough Device Designation’ for Datar Cancer Genetics’ ‘TriNetra’ blood test for breast cancer.
Read More
MYND Diagnostics Researching Alzheimer’s Biomarker
MYND Diagnostics began clinical research on a new test for diagnosing and monitoring Alzheimer’s Disease via an anti-inflammatory peptide biomarker.
Read More
PSA Testing Rates Increased After National Guidelines Revised
In a large study, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions by the USPSTF on screening.
Read More